{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:37:24Z","timestamp":1774543044569,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,17]]},"DOI":"10.7759\/cureus.17258","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T19:14:04Z","timestamp":1629227644000},"source":"Crossref","is-referenced-by-count":4,"title":["Stem Cell Therapy and Its Significance in Pain Management"],"prefix":"10.7759","author":[{"given":"Jaskamal","family":"Padda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizer","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujala","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam","family":"Al Hennawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayant","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulelah H","family":"Almanie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krutagni Adwait","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahriba","family":"Tasnim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayden Charlene","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gutteridge","family":"Jean-Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094853","article-title":"Stem cell therapy for modulating neuroinflammation in neuropathic pain","volume":"22","author":"Joshi HP","year":"2021","unstructured":"Joshi HP, Jo HJ, Kim YH, An SB, Park CK, Han I. Stem cell therapy for modulating neuroinflammation in neuropathic pain. Int J Mol Sci. 2021, 22:4853. 10.3390\/ijms22094853","journal-title":"Int J Mol Sci"},{"key":"ref2","unstructured":"Evaluation of chronic non-cancer pain in adults. (2021). Accessed. August 4, 2021: https:\/\/www.uptodate.com\/contents\/116196."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.17226\/13172","article-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Press, Washington, DC; 2011. 10.17226\/13172"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2019.32.4.245","article-title":"Stem cell therapy in pain medicine","volume":"32","author":"Han YH","year":"2019","unstructured":"Han YH, Kim KH, Abdi S, Kim TK. Stem cell therapy in pain medicine. Korean J Pain. 2019, 32:245-55. 10.3344\/kjp.2019.32.4.245","journal-title":"Korean J Pain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JCN.0b013e318197a6a5","article-title":"Introduction to stem cell therapy","volume":"24","author":"Biehl JK","year":"2009","unstructured":"Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009, 24:98-103. 10.1097\/JCN.0b013e318197a6a5","journal-title":"J Cardiovasc Nurs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi K","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131:861-72. 10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1385\/1-59745-005-7:35","article-title":"Isolation of stromal stem cells from human adipose tissue","volume":"325","author":"Boquest AC","year":"2006","unstructured":"Boquest AC, Shahdadfar A, Brinchmann JE, Collas P. Isolation of stromal stem cells from human adipose tissue. Methods Mol Biol. 2006, 325:35-46. 10.1385\/1-59745-005-7:35","journal-title":"Methods Mol Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000057525.13182.24","article-title":"Stem cell therapy in perspective","volume":"107","author":"Strauer BE","year":"2003","unstructured":"Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation. 2003, 107:929-34. 10.1161\/01.cir.0000057525.13182.24","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy","volume":"6","author":"Glenn JD","year":"2014","unstructured":"Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 2014, 6:526-39. 10.4252\/wjsc.v6.i5.526","journal-title":"World J Stem Cells"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3171\/2013.6.FOCUS13235","article-title":"Potential role of stem cells for neuropathic pain disorders","volume":"35","author":"Vadivelu S","year":"2013","unstructured":"Vadivelu S, Willsey M, Curry DJ, McDonald JW 3rd. Potential role of stem cells for neuropathic pain disorders. Neurosurg Focus. 2013, 35:E11. 10.3171\/2013.6.FOCUS13235","journal-title":"Neurosurg Focus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S63361","article-title":"A preliminary report on stem cell therapy for neuropathic pain in humans","volume":"7","author":"Vickers ER","year":"2014","unstructured":"Vickers ER, Karsten E, Flood J, Lilischkis R. A preliminary report on stem cell therapy for neuropathic pain in humans. J Pain Res. 2014, 7:255-63. 10.2147\/JPR.S63361","journal-title":"J Pain Res"},{"key":"ref12","article-title":"Stem cell therapy for chronic pain management: review of uses, advances, and adverse effects","volume":"20","author":"Chakravarthy K","year":"2017","unstructured":"Chakravarthy K, Chen Y, He C, Christo PJ. Stem cell therapy for chronic pain management: review of uses, advances, and adverse effects. Pain Physician. 2017, 20:293-305.","journal-title":"Pain Physician"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2016.55","article-title":"Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic","volume":"2","author":"Zhou JY","year":"2016","unstructured":"Zhou JY, Zhang Z, Qian GS. Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic. Cell Death Discov. 2016, 2:16055. 10.1038\/cddiscovery.2016.55","journal-title":"Cell Death Discov"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8945310","article-title":"Autologous bone marrow-derived stem cells for treating diabetic neuropathy in metabolic syndrome","volume":"2017","author":"Liu W","year":"2017","unstructured":"Liu W, Yu F, Zhou Z, Li YC, Fan D, Zhu K. Autologous bone marrow-derived stem cells for treating diabetic neuropathy in metabolic syndrome. Biomed Res Int. 2017, 2017:8945310. 10.1155\/2017\/8945310","journal-title":"Biomed Res Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2012-0122","article-title":"Concise review: stem cell therapies for neuropathic pain","volume":"2","author":"Fortino VR","year":"2013","unstructured":"Fortino VR, Pelaez D, Cheung HS. Concise review: stem cell therapies for neuropathic pain. Stem Cells Transl Med. 2013, 2:394-9. 10.5966\/sctm.2012-0122","journal-title":"Stem Cells Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2012-0025","article-title":"Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy","volume":"1","author":"Waterman RS","year":"2012","unstructured":"Waterman RS, Morgenweck J, Nossaman BD, Scandurro AE, Scandurro SA, Betancourt AM. Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl Med. 2012, 1:557-65. 10.5966\/sctm.2012-0025","journal-title":"Stem Cells Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2012.0398","article-title":"Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy","volume":"22","author":"Sacerdote P","year":"2013","unstructured":"Sacerdote P, Niada S, Franchi S, et al.. Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy. Stem Cells Dev. 2013, 22:1252-63. 10.1089\/scd.2012.0398","journal-title":"Stem Cells Dev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/jss.2019.09.22","article-title":"Stem cell therapy in discogenic back pain","volume":"5","author":"Barakat AH","year":"2019","unstructured":"Barakat AH, Elwell VA, Lam KS. Stem cell therapy in discogenic back pain. J Spine Surg. 2019, 5:561-83. 10.21037\/jss.2019.09.22","journal-title":"J Spine Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100050206","article-title":"Degeneration and the chemical composition of the human lumbar intervertebral disc","volume":"5","author":"Pearce RH","year":"1987","unstructured":"Pearce RH, Grimmer BJ, Adams ME. Degeneration and the chemical composition of the human lumbar intervertebral disc. J Orthop Res. 1987, 5:198-205. 10.1002\/jor.1100050206","journal-title":"J Orthop Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-1535-0_11","article-title":"Pathogenesis of intervertebral disc degeneration","author":"Richardson SM","year":"2014","unstructured":"Richardson SM, Freemont AJ, Hoyland JA. Pathogenesis of intervertebral disc degeneration. The Intervertebral Disc. Shapiro I, Risbud M (ed): Springer, Vienna; 2014. 177-200. 10.1007\/978-3-7091-1535-0_11"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)02135-1","article-title":"Nerve ingrowth into diseased intervertebral disc in chronic back pain","volume":"350","author":"Freemont AJ","year":"1997","unstructured":"Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997, 350:178-81. 10.1016\/s0140-6736(97)02135-1","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181ccc220","article-title":"Long-term outcomes of lumbar fusion among workers' compensation subjects: a historical cohort study","volume":"36","author":"Nguyen TH","year":"2011","unstructured":"Nguyen TH, Randolph DC, Talmage J, Succop P, Travis R. Long-term outcomes of lumbar fusion among workers' compensation subjects: a historical cohort study. Spine (Phila Pa 1976). 2011, 36:320-31. 10.1097\/BRS.0b013e3181ccc220","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3171\/2012.10.SPINE12512","article-title":"Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting","volume":"18","author":"Coric D","year":"2013","unstructured":"Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting. J Neurosurg Spine. 2013, 18:85-95. 10.3171\/2012.10.SPINE12512","journal-title":"J Neurosurg Spine"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3908389","article-title":"Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration","volume":"2016","author":"Zeckser J","year":"2016","unstructured":"Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration. Stem Cells Int. 2016, 2016:3908389. 10.1155\/2016\/3908389","journal-title":"Stem Cells Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-013-3007-y","article-title":"The transpedicular approach for the study of intervertebral disc regeneration strategies: in vivo characterization","volume":"22","author":"Vadal\u00e0 G","year":"2013","unstructured":"Vadal\u00e0 G, De Strobel F, Bernardini M, Denaro L, D'Avella D, Denaro V. The transpedicular approach for the study of intervertebral disc regeneration strategies: in vivo characterization. Eur Spine J. 2013, 22:S972-8. 10.1007\/s00586-013-3007-y","journal-title":"Eur Spine J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross M","year":"2014","unstructured":"Cross M, Smith E, Hoy D, et al.. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014, 73:1323-30. 10.1136\/annrheumdis-2013-204763","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","unstructured":"Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015, 386:743-800. 10.1016\/S0140-6736(15)60692-4","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1104-0","article-title":"Do early life factors affect the development of knee osteoarthritis in later life: a narrative review","volume":"18","author":"Antony B","year":"2016","unstructured":"Antony B, Jones G, Jin X, Ding C. Do early life factors affect the development of knee osteoarthritis in later life: a narrative review. Arthritis Res Ther. 2016, 18:202. 10.1186\/s13075-016-1104-0","journal-title":"Arthritis Res Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/art.24021","article-title":"Lifetime risk of symptomatic knee osteoarthritis","volume":"59","author":"Murphy L","year":"2008","unstructured":"Murphy L, Schwartz TA, Helmick CG, et al.. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008, 59:1207-13. 10.1002\/art.24021","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X09359889","article-title":"Current evidence for osteoarthritis treatments","volume":"2","author":"Anandacoomarasamy A","year":"2010","unstructured":"Anandacoomarasamy A, March L. Current evidence for osteoarthritis treatments. Ther Adv Musculoskelet Dis. 2010, 2:17-28. 10.1177\/1759720X09359889","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22412","article-title":"Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty","volume":"67","author":"Losina E","year":"2015","unstructured":"Losina E, Paltiel AD, Weinstein AM, et al.. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res (Hoboken). 2015, 67:203-15. 10.1002\/acr.22412","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang Y","year":"2010","unstructured":"Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010, 26:355-69. 10.1016\/j.cger.2010.03.001","journal-title":"Clin Geriatr Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12670","article-title":"Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients","volume":"19","author":"Davatchi F","year":"2016","unstructured":"Davatchi F, Sadeghi Abdollahi B, Mohyeddin M, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2016, 19:219-25. 10.1111\/1756-185X.12670","journal-title":"Int J Rheum Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110614","article-title":"Pathophysiological perspective of osteoarthritis","volume":"56","author":"Yunus MH","year":"2020","unstructured":"Yunus MH, Nordin A, Kamal H. Pathophysiological perspective of osteoarthritis. Medicina (Kaunas). 2020, 56:614. 10.3390\/medicina56110614","journal-title":"Medicina (Kaunas)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901206010320","article-title":"Pain treatment in arthritis-related pain: beyond NSAIDs","volume":"6","author":"van Laar M","year":"2012","unstructured":"van Laar M, Pergolizzi JV Jr, Mellinghoff HU, et al.. Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J. 2012, 6:320-30. 10.2174\/1874312901206010320","journal-title":"Open Rheumatol J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009332","article-title":"Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections","volume":"5","author":"Freitag J","year":"2015","unstructured":"Freitag J, Ford J, Bates D, et al.. Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections. BMJ Open. 2015, 5:e009332. 10.1136\/bmjopen-2015-009332","journal-title":"BMJ Open"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1391-0","article-title":"Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial","volume":"19","author":"Wang Y","year":"2017","unstructured":"Wang Y, Shimmin A, Ghosh P, et al.. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017, 19:180. 10.1186\/s13075-017-1391-0","journal-title":"Arthritis Res Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2018.08.005","article-title":"Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial","volume":"20","author":"Emadedin M","year":"2018","unstructured":"Emadedin M, Labibzadeh N, Liastani MG, et al.. Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018, 20:1238-46. 10.1016\/j.jcyt.2018.08.005","journal-title":"Cytotherapy"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial","volume":"99","author":"Vega A","year":"2015","unstructured":"Vega A, Mart\u00edn-Ferrero MA, Del Canto F, et al.. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015, 99:1681-90. 10.1097\/TP.0000000000000678","journal-title":"Transplantation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1195-7","article-title":"Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint","volume":"18","author":"Gupta PK","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M, et al.. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016, 18:301. 10.1186\/s13075-016-1195-7","journal-title":"Arthritis Res Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/SCCAA.S268940","article-title":"Clinical applicability of adult human mesenchymal stem cell therapy in the treatment of knee osteoarthritis","volume":"13","author":"Buzaboon N","year":"2020","unstructured":"Buzaboon N, Alshammary S. Clinical applicability of adult human mesenchymal stem cell therapy in the treatment of knee osteoarthritis. Stem Cells Cloning. 2020, 13:117-36. 10.2147\/SCCAA.S268940","journal-title":"Stem Cells Cloning"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017, 390:1211-59. 10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-809880-6.00054-0","article-title":"Stem cell therapy for musculoskeletal diseases","author":"Rothrauff BB","year":"2019","unstructured":"Rothrauff BB, Pirosa A, Lin H, Sohn J, Langhans MT, Tuan RS. Stem cell therapy for musculoskeletal diseases. Principles of Regenerative Medicine (Third Edition). Atala A, Lanza R, Mikos AG, Nerem R (ed): Elsevier Inc., Amsterdam; 2019. 953-70. 10.1016\/B978-0-12-809880-6.00054-0"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny256","article-title":"Office-based mesenchymal stem cell therapy for the treatment of musculoskeletal disease: a systematic review of recent human studies","volume":"20","author":"Law L","year":"2019","unstructured":"Law L, Hunt CL, van Wijnen AJ, et al.. Office-based mesenchymal stem cell therapy for the treatment of musculoskeletal disease: a systematic review of recent human studies. Pain Med. 2019, 20:1570-83. 10.1093\/pm\/pny256","journal-title":"Pain Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/953510","article-title":"Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup","volume":"2012","author":"Pascual-Garrido C","year":"2012","unstructured":"Pascual-Garrido C, Rol\u00f3n A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012, 2012:953510. 10.1155\/2012\/953510","journal-title":"Stem Cells Int"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/BCO.0000000000000218","article-title":"Autologous mesenchymal stem cell implantation in the management of osteonecrosis of the femoral head","volume":"26","author":"Yan D","year":"2015","unstructured":"Yan D, Chen L, Li Z, Guo W, Sun W. Autologous mesenchymal stem cell implantation in the management of osteonecrosis of the femoral head. Curr Orthop Pract. 2015, 26:265-8. 10.1097\/BCO.0000000000000218","journal-title":"Curr Orthop Pract"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu MM","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, et al.. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012, 7:e47559. 10.1371\/journal.pone.0047559","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2019.0421","article-title":"The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Chen W, Feng B, Cao H. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis. Aging Dis. 2020, 11:141-53. 10.14336\/AD.2019.0421","journal-title":"Aging Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175449","article-title":"Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis","volume":"12","author":"Yubo M","year":"2017","unstructured":"Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C. Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis. PLoS One. 2017, 12:e0175449. 10.1371\/journal.pone.0175449","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151938","article-title":"Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis","volume":"11","author":"El-Badawy A","year":"2016","unstructured":"El-Badawy A, El-Badri N. Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis. PLoS One. 2016, 11:e0151938. 10.1371\/journal.pone.0151938","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel MP","year":"2012","unstructured":"De Miguel MP, Fuentes-Juli\u00e1n S, Bl\u00e1zquez-Mart\u00ednez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med. 2012, 12:574-91. 10.2174\/156652412800619950","journal-title":"Curr Mol Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"R\u00f8sland GV","year":"2009","unstructured":"R\u00f8sland GV, Svendsen A, Torsvik A, et al.. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009, 69:5331-9. 10.1158\/0008-5472.CAN-08-4630","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213506802","article-title":"Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells","volume":"239","author":"Pan Q","year":"2014","unstructured":"Pan Q, Fouraschen SM, de Ruiter PE, Dinjens WN, Kwekkeboom J, Tilanus HW, van der Laan LJ. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. Exp Biol Med (Maywood). 2014, 239:105-15. 10.1177\/1535370213506802","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66003-stem-cell-therapy-and-its-significance-in-pain-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:54Z","timestamp":1707507234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66003-stem-cell-therapy-and-its-significance-in-pain-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.17258","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,17]]}}}